19 May 2016 – The Age: Superbugs will kill 10 million people a year by 2050 This recent article published in The Age describes a call to action from Britain’s chancellor, George Osborne, to the finance ministers from around the world, to agree on a common approach to fight the threat of antibiotic-resistant bacteria at the September…

Dr. Doug Millar, Genetic Signatures Chief Scientific Officer, presented a scientific poster titled “A Rapid 3base™ Real-Time PCR for the detection of Extended Spectrum Beta-Lactamase and Carbapenemase-Producing Organisms using Multi-Coloured Fluorogenic Probes“ at the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Amsterdam, Netherlands. The data presented showed that the Genetic Signatures…

Molecular diagnostics (MDx) company Genetic Signatures is attending the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), to be held on 9-12 April 2016 in Amsterdam, Netherlands. Dr Douglas Millar, Genetic Signatures Chief Scientific Officer, will present a scientific poster titled “A Rapid 3base™ Real-Time PCR for the detection of Extended Spectrum Beta-Lactamase…

Two scientific presentations given at the recent 5th Molecular Microbiology Meeting in Sydney, Australia have described the superior performance of Genetic Signatures EasyScreen™ Pathogen Detection Kits. The first presentation titled “Pathogenicity of Dientamoeba fragilis” by Damien Stark of Sydpath, NSW reported the use of the EasyScreen™ Protozoan Detection Kit for the improved detection of D.…

AusBiotech is the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy. AusBiotech marked 30 years since the industry organisation was founded on 28 December 2015. As part of the 2016 celebrations of this event, the organisation is publishing ’30 success stories in 30 days’ in…

Notice of 2015 Annual General Meeting

Dr Douglas Millar, Chief Scientific Officer of Genetic Signatures, has recently released a paper describing his work on directed enzyme evolution in collaboration with Dr Philipp Holliger, of the MRC laboratory for Molecular Biology in Cambridge UK. The paper “A polymerase engineered for bisulfite sequencing” published in Nucleic Acids Res. describes 5D4, an engineered DNA…

Molecular diagnostics (MDx) company Genetic Signatures will exhibit and present scientific data at the 43rd Annual Scientific Meeting and Trade Exhibition of the Australian Society for Microbiology which will be held on the 12th to 15th of July 2015 in Canberra, Australia. Dylan Warby, Genetic Signatures Sales and Marketing Manager, will present a scientific poster titled Comparison…

Alan Kohler of the Eureka report recently interviewed Genetic Signatures CEO Dr John Melki. Dr Melki spoke about the history of Genetic Signatures and his own 12-year involvement with the company, and 20 years experience using the tools that form the basis of its 3base™ technology. Alan queried John about Genetic Signatures products, financial results…

Molecular diagnostics (MDx) company Genetic Signatures will exhibit and present scientific data at the 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), which will be held on 25 – 28 April 2015 in Copenhagen, Denmark. Dr Doug Millar, Genetic Signatures Chief Scientific Officer, will present a scientific poster titled “Comparison of the Efficiency…